Gabapentin

This classification denotes a sedative and hypnotic with the molecular formula C9H17NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6CW7F3G59X, chemically known as cyclohexaneacetic acid, 1-(aminomethyl)- but generally known as gabapentin, which bears US NIH Compound Identifier 3446. European Medicines Agency schedules Gabapentin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07857MIG. The term GABAPENTIN is an International Non-Proprietary Name. World Health Organization schedules gabapentin in its Anatomical Therapeutic Chemical (ATC) Classification. GABAPENTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gabapentin under HS 29224995 and SITC 51465. As of Q4 2014, GABAPENTIN remains the US FDA Preferred Term for this commodity. Gabapentin bears US NLM identifiers UMLS ID C0060926 and NCI Concept Code C1108. SMILES: OC(=O)CC1(CCCCC1)CN.